ADU-S100can normalize tumor vascularity and induce the formation of tertiary lymphoid structure in a tumor microenvironment (106), thereby promoting activated CD8+ T-cell infiltrate peritoneal tumor nodules (107). Here, CD8A is linked to neoplasm.